Distinct Effects of IL-18 on the Engraftment and Function of Human Effector CD8+ T Cells and Regulatory T Cells
Open Access
- 26 September 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (9) , e3289
- https://doi.org/10.1371/journal.pone.0003289
Abstract
IL-18 has pleotropic effects on the activation of T cells during antigen presentation. We investigated the effects of human IL-18 on the engraftment and function of human T cell subsets in xenograft mouse models. IL-18 enhanced the engraftment of human CD8+ effector T cells and promoted the development of xenogeneic graft versus host disease (GVHD). In marked contrast, IL-18 had reciprocal effects on the engraftment of CD4+CD25+Foxp3+ regulatory T cells (Tregs) in the xenografted mice. Adoptive transfer experiments indicated that IL-18 prevented the suppressive effects of Tregs on the development of xenogeneic GVHD. The IL-18 results were robust as they were observed in two different mouse strains. In addition, the effects of IL-18 were systemic as IL-18 promoted engraftment and persistence of human effector T cells and decreased Tregs in peripheral blood, peritoneal cavity, spleen and liver. In vitro experiments indicated that the expression of the IL-18Rα was induced on both CD4 and CD8 effector T cells and Tregs, and that the duration of expression was less sustained on Tregs. These preclinical data suggest that human IL-18 may have use as an adjuvant for immune reconstitution after cytotoxic therapies, and to augment adoptive immunotherapy, donor leukocyte infusions, and vaccine strategies.Keywords
This publication has 65 references indexed in Scilit:
- An IFN-γ-IL-18 Signaling Loop Accelerates Memory CD8+ T Cell ProliferationPLOS ONE, 2008
- Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patientsProceedings of the National Academy of Sciences, 2008
- Host-Derived Interleukin-18 Differentially Impacts Regulatory and Conventional T Cell Expansion During Acute Graft-Versus-Host DiseaseTransplantation and Cellular Therapy, 2007
- Cellular targets of interleukin-18 in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Principles of adoptive T cell cancer therapyJournal of Clinical Investigation, 2007
- Tregs and rethinking cancer immunotherapyJournal of Clinical Investigation, 2007
- Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progressionCancer and Metastasis Reviews, 2006
- CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cellsJournal of Clinical Investigation, 2006
- T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotypeBlood, 2006
- Immunohistochemical and immuno-electron-microscopic detection of interferon-γ-inducing factor (”interleukin-18") in mouse intestinal epithelial cellsCell and tissue research, 1997